Buspirone Hydrochloride
Product Images NDC 21695-195

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 21695-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (4b044819 2959 4914 B564 D944201246fd 01)

Chemical structure of buspirone hydrochloride as depicted in the image showing its molecular framework including a bicyclic ring system and nitrogen atoms characteristic of the compound.*

FDA Label Image

15 mg (the Entire Tablet) (4b044819 2959 4914 B564 D944201246fd 02)

Buspirone Hydrochloride tablet imprint showing a capsule-shaped white pill marked with the number '5' on each of three segments. No other labeling or markings are visible in the image.*

FDA Label Image

10 mg (two-thirds Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 03)

The image shows one white, capsule-shaped tablet bisected by a score line with the imprint '5 5'. The tablet is identified as Buspirone Hydrochloride, likely in a 5 mg strength, from Rebel Distributors Corp, product NDC 21695-195.*

FDA Label Image

5 mg (one-third Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 04)

Tablet imprinted with the number '5' on one side and a distinct scored line separating its rounded edge. The image shows the tablet's imprint used for identifying the medication, consistent with Buspirone Hydrochloride tablets by Rebel Distributors Corp, NDC 21695-195.*

FDA Label Image

7.5 mg (one-half Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 05)

Buspirone Hydrochloride tablet imprint featuring the letter 'M' on a capsule-shaped white tablet, as manufactured by Rebel Distributors Corp under NDC 21695-195.*

FDA Label Image

30 mg (the Entire Tablet) (4b044819 2959 4914 B564 D944201246fd 06)

Buspirone Hydrochloride 10 mg tablet imprint showing the number '10' repeated three times across the capsule-shaped tablet. The image highlights the pill's identifying imprint used for recognition. Labeler: Rebel Distributors Corp.*

FDA Label Image

20 mg (two-thirds Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 07)

Buspirone Hydrochloride tablet with an imprint of '10' on both sides, indicating a 10 mg dosage. The tablet is biconvex and white. The image does not show any packaging or labeler details.*

FDA Label Image

10 mg (one-third Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 08)

Buspirone Hydrochloride tablet imprint showing the number '10' on one side. The shape of the tablet segment resembles a rounded rectangle with a flat side.*

FDA Label Image

15 mg (one-half Of A Tablet) (4b044819 2959 4914 B564 D944201246fd 09)

Buspirone Hydrochloride tablet imprinted with "M" on one side in black on white. The tablet is capsule-shaped and solid in color. No other markings or labeler information visible.*

FDA Label Image

Breaking Tablet (4b044819 2959 4914 B564 D944201246fd 10)

An instructional line drawing showing two hands holding a tablet, demonstrating the technique of breaking the tablet in half along a scored line for splitting.*

FDA Label Image

Buspirone HCl 30mg (4b044819 2959 4914 B564 D944201246fd 11)

Buspirone HCL 30mg tablets packaging label from Rebel Distributors Corp with NDC 21695-195-30. The label shows a package count of 30 tablets and includes identification details such as lot and expiration number placeholders. Packaging is marked RX Only and shows Physician Partner branding, with storage instructions to keep at controlled room temperature (15-30°C) and warnings to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.